These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 10354061)

  • 1. The time course of phototoxicity of topical PUVA: 8-methoxypsoralen cream-PUVA vs. 8-methoxypsoralen gel-PUVA.
    Grundmann-Kollmann M; Leiter U; Behrens S; Gottlöber P; Mooser G; Krähn G; Kerscher M
    Br J Dermatol; 1999 May; 140(5):988-90. PubMed ID: 10354061
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of PUVA bath phototoxicity.
    Neumann NJ; Kerscher M; Ruzicka T; Lehmann P
    Acta Derm Venereol; 1997 Sep; 77(5):385-7. PubMed ID: 9298134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid decrease of phototoxicity after PUVA bath therapy with 8-methoxypsoralen.
    Neumann NJ; Ruzicka T; Lehmann P; Kerscher M
    Arch Dermatol; 1996 Nov; 132(11):1394. PubMed ID: 8915329
    [No Abstract]   [Full Text] [Related]  

  • 6. Phototesting and phototoxic side effects in bath PUVA.
    Calzavara-Pinton PG; Ortel B; Carlino AM; Honigsmann H; De Panfilis G
    J Am Acad Dermatol; 1993 Apr; 28(4):657-9. PubMed ID: 8463475
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contact allergy to 8-methoxypsoralen.
    Korffmacher H; Hartwig R; Matthes U; Dirschka T; Albassam A; Weindorf N; Altmeyer P
    Contact Dermatitis; 1994 May; 30(5):283-5. PubMed ID: 8088142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PUVA-induced phototoxicity: incidence and causes.
    Morison WL; Marwaha S; Beck L
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):183-5. PubMed ID: 9039165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved prediction of the minimal phototoxic dose in PUVA therapy.
    Sakuntabhai A; Matthews JN; Farr PM
    Br J Dermatol; 1994 May; 130(5):604-9. PubMed ID: 8204468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid decline in photosensitivity after 8-methoxypsoralen bathwater delivery.
    Degitz K; Plewig G; Röcken M
    Arch Dermatol; 1996 Nov; 132(11):1394-5. PubMed ID: 8915330
    [No Abstract]   [Full Text] [Related]  

  • 12. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
    Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
    Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reproducible elevation of liver transaminases by topical 8-methoxypsoralen.
    Park YM; Kim TY; Kim HO; Kim CW
    Photodermatol Photoimmunol Photomed; 1994 Dec; 10(6):261-3. PubMed ID: 7727284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP).
    Ravenscroft J; Goulden V; Wilkinson M
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S218-9. PubMed ID: 11712064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics and dose-response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations.
    Grundmann-Kollmann M; Tegeder I; Ochsendorf FR; Zollner TM; Ludwig R; Kaufmann R; Podda M
    Br J Dermatol; 2001 May; 144(5):991-5. PubMed ID: 11359386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phototoxic contact dermatitis from 5-methoxypsoralen in aromatherapy oil.
    Clark SM; Wilkinson SM
    Contact Dermatitis; 1998 May; 38(5):289-90. PubMed ID: 9667455
    [No Abstract]   [Full Text] [Related]  

  • 18. Localized vitiligo successfully treated with cream-psoralen + ultraviolet A.
    Kreuter A; Gambichler T; Avermaete A; Jansen T; Altmeyer P; von Kobyletzki G
    J Eur Acad Dermatol Venereol; 2001 Jul; 15(4):357-8. PubMed ID: 11730053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cream PUVA photochemotherapy].
    Stege H; Berneburg M; Ruzicka T; Krutmann J
    Hautarzt; 1997 Feb; 48(2):89-93. PubMed ID: 9173066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term stability of 8-methoxypsoralen in ointments for topical PUVA therapy ('Cream-PUVA').
    Martens-Lobenhoffer J; Rinke M; Lösche D; Gollnick H
    Skin Pharmacol Appl Skin Physiol; 1999; 12(5):266-70. PubMed ID: 10461095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.